-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Federal Pharmaceuticals (03933.HK) announced that on July 15, 2026, Federal Biotech has received US$13.5 million (after deducting Danish withholding tax) from Novo Nordisk for UBT251 injection global phase I clinical milestone payments for overweight or obesity indications.

Zhitongcaijing·07/16/2026 04:09:05
Listen to the news
Zhitong Finance App News, Federal Pharmaceuticals (03933.HK) announced that on July 15, 2026, Federal Biotech has received US$13.5 million (after deducting Danish withholding tax) from Novo Nordisk for UBT251 injection global phase I clinical milestone payments for overweight or obesity indications.